Eczema treatments have flourished in the last few years, meaning no one should have to suffer without relief. Eczema is a ...

The FDA accepted a new drug application for a single inhaler that contains beclomethasone dipropionate, formoterol fumarate ...

The FDA has accepted for review Chiesi’s New Drug Application (NDA) for their investigational maintenance treatment for ...

Learn the 5 key questions parents should ask about their child’s eczema treatment—including safe, steroid-free options and ...

The phase 3 EXHALE-4 study demonstrated that dexpramipexole, an oral small molecule therapy, significantly improved ...

Châtillon, France, October 30, 2025DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting DBV ...

Anti-IL5 therapy significantly reduces moderate and severe exacerbations in asthma and COPD, preventing major ...

Treatment for chronic hives lasting at least 6 weeks may include one or more types of medication, as well as certain ...

CHICAGO -- A fixed-dose inhaler combining an inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting beta agonist (ICS/LAMA/LABA) improved lung function and reduced exacerbations in ...

More than 31 million people in the U.S. live with eczema, a chronic skin condition that can disrupt daily life yet continues ...

Findings showed Staloral Birch, compared with placebo, demonstrated a 41% improvement in the ARC total combined score during the second pollen season. Topline data were announced from a phase 3b trial ...